Anticancer Bioscience Expands its R&D and Headquarters with a Relocation to Tianfu International Biotown, China
Chengdu, China, December 20, 2021 – Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced today that to accommodate its growth and expansion, and on the back of its recent financing, it has relocated to the Tianfu International Biotown, in Chengdu, China. Biotown is the premier biotech research park in Chengdu, the capital of Sichuan province.
